Meta-analysis of cytomegalovirus seroprevalence in volunteer blood donors and healthy subjects in Iran from ۱۹۹۲ to ۲۰۱۳

Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 211

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-18-7_001

تاریخ نمایه سازی: 3 آبان 1400

Abstract:

Objective(s):Human cytomegalovirus (CMV), a double-strand DNA herpesvirus, can be transmitted via blood transfusion which is especially important for immunocompromised recipients and can cause a fatal infection. CMV seroprevalence in Iran was studied on blood donors, healthy subjects, and some patients. Highly variable rates were detected. The purpose of this study was to review CMV seroprevalence in blood donors and apparently healthy individuals, in Iran.[m۱]  Materials and Methods: One hundred and fifty-eight electronic and paper-based resources and databases including published articles in internal and external journals, seminars, dissertations, and theses available in the databaseand different websites were used to be systematically reviewed as a meta-analysis. Less related articles to the issue, papers of specific high risk population, and articles with not enough information, were excluded. Eventually ۲۲ articles that satisfied our selection criteria were systematically reviewed and analyzed. To explore heterogeneity between studies the I square (I۲) index was used. Data were analyzed using the statistical software package (STATA) ۱۱. Results: The heterogeneity between selected studies was ۹۷% with an I۲ statistic. In this study a random effects model was used for meta-analysis. The prevalence of CMV IgG and CMV IgM antibodies in the country were estimated to be ۹۲% (۹۵% CI: ۹۰-۹۴) and ۲.۶% (۹۵% CI: ۱.۷-۳.۶), respectively. Conclusion: Given high rate of CMV seropositivity in Iran, it seems that CMVAbs screening would not be a reasonable and affordable approach to prevent CMV infection via transfusion especially for immune compromised recipients, so alternative strategies should be considered.

Authors

Mojgan Shaiegan

Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Immunohematology Department, Tehran, Iran

Mahbobeh Rasouli

Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran

Maryam Zadsar

Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Microbilogy Department, Tehran, Iran

Sima Zolfaghari

Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Immunohematology Department, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • ۱.Piri S. Cytomegalovirus infection in pregnancy.J Iran Obs Gynec ۲۰۱۱; ...
  • ۲.Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, ...
  • ۴.Jain M, Duggal S, Das Chugh T. Cytomegalovirus infection in ...
  • ۵.Lopo S, Vinagre E, Palminha P, Paixao MT, Nogueira P, ...
  • ۶.Munro SC, Hall B, Whybin LR, Leader L, Robertson P ...
  • ۷.Aghaeipour M, Tarabadi FA, Shaeigan M, Babaei GR. Detection of ...
  • ۸.Tarabadi F, Ghaledi J, Shaeigan M, Babaei GR. Comparison of ...
  • ۹.Tarabadi F, Aghaeipour M, Shaiegan M, Babaei GR: Correlation between ...
  • ۱۰.Khameneh ZR. Occurrence of cytomegalovirus infection and factors causing reactivation ...
  • ۱۱.Asadi MH, Esmaeilzadeh AR. Frequency of cytomegalovirus antibodies (IgG and ...
  • ۱۲.Delfan-Beiranvand M, Sheikhian A, Birjandi M, Fazeli Ml. Seroprevalence of ...
  • ۱۳.Safabakhsh H, Tehranian F, Tehranian B, Hatami H, Karimi G,Shahabi ...
  • ۱۴.Moniri R, Mosayebii Z, Mossavi GA. Seroprevalence of cytomegalovirus, hepatitis ...
  • ۱۵.Mostafavi SN, Ataei B, Nokhodian Z, Yaran B, Babak A, ...
  • ۱۶.Mostafavi SN, Ataei. B, Salehi A, Nokhodian Z, Yaran, M, ...
  • ۱۷.Hashemzadeh Z, Motamedifar M. The comparison of ELISA test and ...
  • ۱۸.Zandieh T, Kavian S, Rakhshan M. The evaluation of cytomegalovirus ...
  • ۱۹.Noorbakhsh S, Farhadi M, Tabatabaei A. Cytomegalovirus, a common cause ...
  • ۲۰.Sanadgol N, Ramroodi N, Ahmadi GA, Komijani M, Moghtaderi A ...
  • ۲۱.Hejazi S, Molla-Abaszadeh A, Karamiyar M. Prevalence of anti-CMV antibodies ...
  • ۲۲.Abdollahi A, Shoar S, Sheikhbahaei S, Jafari S. Sero-prevalence of ...
  • ۲۳.Tarabadi F, Babaei G R, Hashemi E, Broumand B, Shaiegan ...
  • ۲۴.Hamkar R, Azarian B, Saadatmand Z. Sero-epidemiology of CMV in ...
  • ۲۵.Vahdat K, Jafari SM, Pazoki R, Nabipour I. Current sensitivity ...
  • ۲۶.Arabpour M, Kaviyanee K, Jankhah A, Yaghobi R. Human cytomegalovirus ...
  • ۲۷.Choobineh H, Alizadeh SH, Sharifi –Yazdi MK, Vaezzadeh F, Dargahi ...
  • ۲۸.Saghafi H, Qorashi M, Heidar A. Is screening for IgG ...
  • ۲۹.Alavi SM, Hasan –Adel SM, Rajabzadeh AR. An Evidence against ...
  • ۳۰.Taiebi D, Tabatabaei M, Rahsaz M, Sharifi S, Shariati M ...
  • ۳۲.Abdolmohammadi K, Ghorban K, Dormanesh B, Dadmanesh M, Zarei S. ...
  • ۳۳.Barazesh A, Zandi K, Hadavand F, Mootamed N, Hafzollah F, ...
  • ۳۴.Adjei A, Armah H, Narter-Olaga E. Seroprevalence of cytomegalovirus among ...
  • ۳۵.Souza MA, Passos AM, Treitinger A, Spada C. Seroprevalence of ...
  • ۳۶.Kothari۱ A, Ramachandran VG, Gupta P, Singh B, Talwar V. ...
  • ۳۷.Amarapal p, Tantivanich S, Balachandra K. Prevalence of Cytomegalovirus in ...
  • ۳۸.Hecker M, Qiu D, Marquardt K, Bein G, Hackstein H. ...
  • ۳۹.Mutlu B, Günlemez A, Türker G, Gokalp AS, Willke A. ...
  • ۴۰.Kumar H, Gupta PK, Kumar S, Sarkar RS. Is seroprevalence ...
  • ۴۱.Akinbami AA, Akanmu AS, Adeyemo TA, Wright KO, Dada MO, ...
  • ۴۲.Kafi S, Eldouma E, Saeed S, Musa H. Seroprevalence of ...
  • ۴۳.Jahan M, Tabassum S, Aziz A, Ahmed M, Islam N. ...
  • ۴۴.Al-Dabbagh KA. Detection of toxoplasma gondii IgM and cytomegalovirus IgM ...
  • ۴۵.Alao O, Mamman A, Araoye MO, Joseph E. Effect of ...
  • ۴۶.Ojide CK, Ophori EA, Eghafona N, Omoti C. Seroprevalence of ...
  • ۴۷.Barah F. Prevalence of herpes simplex types ۱ and ۲, ...
  • ۴۸.Hani A. Seroprevalence of cytomegalovirus in healthy voluntary blood donors ...
  • ۴۹.Furui Y, Satake M, Hoshi Y, Uchida S, Suzuki K, ...
  • ۵۰.Ziemann M, Hennig H. Prevention of transfusion-transmitted cytomegalovirus infections: which ...
  • ۵۱.Amini Kafi-abad S, Ranjbar- Kermani F, Ferdowsian F, Sobhani M, ...
  • نمایش کامل مراجع